JENNIFER BISSON: Open Payments
NPI 1083678171 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 44 payments from 15 companies in 2025. Trend: 2023 $900 · 2024 $724 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $251 |
| AstraZeneca Pharmaceuticals LP | 7 | $136 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $83 |
| PFIZER INC. | 4 | $82 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Amgen Inc. | 3 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Corium, LLC | 1 | $31 |
| Exact Sciences Corporation | 1 | $20 |
Products named: VRAYLAR, AIRSUPRA, QULIPTA, XIFAXAN, CAPLYTA, NURTEC ODT, Kerendia, FARXIGA.
Industry payments across FL — which companies pay providers there.
